BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7699913)

  • 1. [Waldenström's macroglobulinemia].
    Tsuruoka N
    Nihon Rinsho; 1995 Mar; 53(3):725-9. PubMed ID: 7699913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia.
    Martino R; Shah A; Romero P; Brunet S; Sierra J; Domingo-Albós A; Fruchtman S; Isola L
    Bone Marrow Transplant; 1999 Apr; 23(7):747-9. PubMed ID: 10218857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rearrangements of immunoglobulin heavy chain gene in Waldenstr"om's macroglobulinemia].
    Matsuda I; Ishiyama T; Hisatake J; Koike M; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1996 Apr; 37(4):275-9. PubMed ID: 8847796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous Waldenström's macroglobulinemia].
    Mantoux F; Castanet J; Perrin C; Fuzibet JG; Lacour JP; Ortonne JP
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):53-5. PubMed ID: 11937931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waldenström's macroglobulinemia: review of 45 cases.
    Krajny M; Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):899-900, 902, 905. PubMed ID: 817791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
    Pilon AF; Rhee PS; Messner LV
    Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waldenström's macroglobulinemia with an IgM paraprotein that is both a cold agglutinin and a cryoglobulin and has a suppressive effect on progenitor cell growth.
    Zago-Novaretti M; Khuri F; Miller KB; Berkman EM
    Transfusion; 1994 Oct; 34(10):910-4. PubMed ID: 7940666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of small cell lung cancer with Waldenstrom's macroglobulinemia].
    Nakayama Y; Natsuaki M; Itoh T; Nishioka K
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Jun; 40(6):1021-4. PubMed ID: 1321869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral central retinal vein occlusion in Waldenström's macroglobulinemia.
    Avashia JH; Fath DF
    J Am Optom Assoc; 1989 Sep; 60(9):657-8. PubMed ID: 2507620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waldenström's macroglobulinemia as a diagnostic challenge: case report.
    Budimir I; Nikolić M; Pusić MS; Hrabar D; Ljubicić N; Duvnjak M; Supanc V; Nikolac I; Babić N; Sokcević M
    Acta Clin Croat; 2014 Mar; 53(1):94-7. PubMed ID: 24974671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polychimiotherapy and Waldenström's macroglobulinemia (author's transl)].
    Barrier J; Grolleau JY; Renault JJ; Ozanne P; Bouret O
    Sem Hop; 1979 Dec 8-15; 55(41-42):1925-6. PubMed ID: 231315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
    Ise M; Sakai C; Kumagai K
    Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous peripheral blood stem cell transplantation for Waldenstrom's macroglobulinemia.
    Yang L; Wen B; Li H; Yang M; Jin Y; Yang S; Tao J
    Bone Marrow Transplant; 1999 Oct; 24(8):929-30. PubMed ID: 10516708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.